Seven in every 100,000 Australian women develop cervical cancer, however researchers estimate this will decrease to fewer than six new cases per 100,000 women by 2020, and to fewer than four new cases by 2028. By 2100 there would be just 3 deaths per million women as compared the current death rate that is 260 deaths each year today, or 21 deaths per million.
"This is such exciting news for women across Australia", Director of Research at Cancer Council NSW Professor Karen Canfell said in a statement on Wednesday.
More than 310,000 women die each year from cervical cancer globally.
Australia was one of the first countries to introduce a national HPV vaccination program for girls in 2007, and it has since been extended to achieve high vaccination coverage across both sexes, according to the study.
However, the current vaccine functions by shielding receivers from the types of HPV that potentially causes 90% of cervical cancer worldwide.
The recent news has been described in the Lancet Public Health Journal, which established that even though global deaths from the disease still exceed 310,000 every year, Australia is heading on the path where cervical cancer would nearly vanish.
Australia could be the first country to eliminate cervical cancer as a result of Queensland's Gardasil vaccine.
Australia moved to a new five-yearly HPV cervical screening test for women aged 25-74 a year ago, which replaced a two-yearly pap smear test.
Music added that progress is also being seen in the UK.
For the same year the CDC reported 12,845 new cases of cervical cancer; for every 100,000 women eight were diagnosed with cervical cancer, making cervical cancer the 20th most common cancer in the US.
Thirty-five countries and territories of the Western Hemisphere last week adopted the Plan of Action for Cervical Cancer Prevention and Control 2018-2030, in the 56th Directing Council of the Pan American Health Organization (PAHO), in Washington, DC.
Now research from Cancer Council NSW argues the most dramatic improvements are still to come, as the first recipients of the early HPV vaccination program begin to reach their mid thirties.
Australia moved to a new five-yearly HPV cervical screening test for women aged 25-74 from last year, replacing the old two-yearly Pap test previously offered from ages 18-69 years.
"We should look to follow their example and introduce new technologies as soon as possible, this includes HPV primary screening, self-sampling as part of the cervical screening programme and vaccinating boys for HPV". The new test can find cell abnormalities from HPV infections before these have surfaced and is expected to lower mortality and cervical cancer cases by 20% according to the study. The country alreadyhas one of the lowest cases of cervical cancers and deaths due to the disease, according to the study.
Cervical cancer screening is available in nearly all the countries of the region, with Pap tests most commonly used.